Info

The hedgehog was engaged in a fight with

Read More
Guidelines

Is JNJ on Nasdaq?

Is JNJ on Nasdaq?

Johnson & Johnson Common Stock (JNJ) Stock Price, Quote, News & History | Nasdaq.

Is JNJ a buy or sell?

For example, a stock trading at $35 with earnings of $3 would have an earnings yield of 0.0857 or 8.57%. A yield of 8.57% also means 8.57 cents of earnings for $1 of investment….Momentum Scorecard. More Info.

Zacks Rank Definition Annualized Return
1 Strong Buy 25.60%
2 Buy 19.21%
3 Hold 10.85%
4 Sell 6.62%

Is Johnson and Johnson a good dividend stock?

During periods of rising interest rates, income investors must be mindful that high-yielding stocks tend to struggle. With that in mind, JNJ is a compelling investment opportunity. Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of 3 (Hold).

What dividend does Johnson & Johnson pay?

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2021. NEW BRUNSWICK, N.J., July 19, 2021 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2021 of $1.06 per share on the company’s common stock.

Is JNJ a good dividend stock?

How much does Johnson & Johnson pay in dividends?

Dividend History for Johnson & Johnson (JNJ)

Ex-Div. Date Amount Pay. Date
8/24/2020 $1.01 9/8/2020
5/22/2020 $1.01 6/9/2020
11/25/2019 $0.95 12/10/2019
8/26/2019 $0.95 9/10/2019

How often does Johnson & Johnson pay dividends?

4 dividends per year
Dividend Summary There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 2.3. Our premium tools have predicted Johnson & Johnson with 99% accuracy. Sign up for Johnson & Johnson and we’ll email you the dividend information when they declare.

Which is the biggest pharmaceutical company in the world?

Top pharmaceutical companies with revenue over $10 billion

Rank Chg Company
1 Johnson & Johnson NYSE: JNJ
2 1 Sinopharm SEHK: 1099
3 1 Roche SIX: ROG
4 7 Pfizer NYSE: PFE

Show less

15 Wall Street analysts have issued 1-year price targets for Johnson & Johnson’s stock. Their forecasts range from $150.00 to $173.00. On average, they anticipate Johnson & Johnson’s share price to reach $160.77 in the next twelve months. This suggests a possible upside of 5.8% from the stock’s current price.

Who are the major shareholders of Johnson and Johnson?

Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol “JNJ.” Who are Johnson & Johnson’s major shareholders? Johnson & Johnson’s stock is owned by a number of institutional and retail investors.

What does the Johnson and Johnson ( JNJ ) vaccine mean for its stock?

What Does the Johnson & Johnson (JNJ) Vaccine Mean For Its Stock? J ohnson & Johnson ( JNJ) yesterday became the latest company to request an emergency use authorization from the FDA for their Covid-19 vaccine.

Is the JNJ stock a good stock to buy?

NYSE:JNJ Johnsons and Johnsons is a stock worth buying at the moment and holding for the next year or so. They are pioneering a vaccine for the coronavirus and is due to be administered late 2020 early 2021. JNJ just entered the fray as the newest bona fide COVID-19 “play” given its claim to have a serious vaccine candidate.

What’s the market cap of Johnson and Johnson?

Market cap (market capitalization) is the total market value of a publicly traded company’s outstanding shares. Johnson & Johnson ‘s market cap is calculated by multiplying JNJ ‘s current stock price of $164.96 by JNJ ‘s total outstanding shares of 2,633,396,003.

What was the stock price of Johnson and Johnson in 1997?

Johnson & Johnson stock was originally listed at a price of $32.94 in Dec 31, 1997. If you had invested in Johnson & Johnson stock at $32.94, your return over the last 23 years would have been 400.79%, for an annualized return of 7.26%. How much is Johnson & Johnson’s stock price per share?

What’s the stock price of Johnson Matthey plc?

Does The Market Have A Low Tolerance For Johnson Matthey Plc’s (LON:JMAT) Mixed Fundamentals? With its stock down 3.2% over the past month, it is easy to disregard Johnson Matthey (LON:JMAT). It seems that the…

NYSE:JNJ Johnsons and Johnsons is a stock worth buying at the moment and holding for the next year or so. They are pioneering a vaccine for the coronavirus and is due to be administered late 2020 early 2021. JNJ just entered the fray as the newest bona fide COVID-19 “play” given its claim to have a serious vaccine candidate.